Industry & Business

TCD bio-pharma company sold for over €5m

 Breaking News
  • Largest Ever European Investment Bank Support in Ireland The European Investment Bank is to provide a loan of €490 million to support construction of the new children’s hospital in Dublin. This represents the largest ever financial engagement by the European Union’s long-term lending institution in Ireland and the EIB’s first backing for a hospital in the country. The new children’s hospital project includes two [...]...
  • Strabane Manufacturer to Invest Over £7 Million in Ambitious Expansion Strabane-based Fabplus is planning to more than double its workforce and turnover with support from Invest Northern Ireland. The investment is part of a three year expansion plan to increase its market share in the Republic of Ireland and Great Britain, and gain a foothold in mainland Europe and Scandinavia. Recruitment is underway to employ 83 additional staff at [...]...
  • PM Group Appoints a New Non-Executive Director Michael McNicholas has been appointed as a Non-Executive Director of Project Management Holdings (PM Group), the Irish headquartered international project delivery specialists. Michael McNicholas. Michael has over 35 years’ experience in senior leadership positions in the public and private sectors. He is the former CEO of Ervia, NTR plc and Managing Director of ESB International.  During his [...]...
  • Center Parcs Signs Contract With John Sisk & Son As construction activity on the much anticipated €233 million Center Parcs Longford Forest resort in County Longford ramps up, the company has announced it has formally awarded two major construction contracts to Dublin-based construction firm John Sisk & Son. The contracts for the construction of the 470 lodges and 30 apartments as well as the state-of-the-art centre [...]...
  • Medi-Shower Invests in Innovation to Drive Export Growth Multi-award-winning manufacturer Medi-Shower has created ‘smart showerhead’ technology which can reduce the risk of Legionnaires disease. The cutting edge product, developed with R&D support from Invest Northern Ireland is designed to meet the high requirements for hygiene within the healthcare sector. It reduces the risk of waterborne infection from bacteria that can build up due to poor design [...]...

TCD bio-pharma company sold for over €5m

March 09
12:38 2016

pharma_chemie_jobs_labA Trinity College Dublin spin-off bio-pharma company has been sold to a US firm for €5.4m and 265,000 shares.

Genable Technologies, which makes gene-based drugs that treat genetic diseases, has been purchased by Spark Therapeutics – an American firm considered a leader in gene therapy.

Genable was set up on campus in Trinity 13 years ago out of the research of Professor Jane Farrar, Dr Paul Kenna and Professor Peter Humphries.

It is expected that the takeover will lead to the research that Genable has worked on being converted into products approved for market.

Among the likely candidates is RhoNova, a potential treatment that targets a form of the eye disease retinitis pigmentosa which can result in visual impairment and even blindness.

The two companies have been working together in the area of inherited retinal disease for the past two years.

“Without doubt at this juncture Spark Therapeutics provides the optimal way for this innovative therapy to progress to patients,” said Professor of Genetics at Trinity, Jane Farrar, who has been involved in building Genable.

According to Trinity College Dublin, shareholders in Genable will receive $6 million following the sale, along with 265,000 shares of Spark common stock.

It did not disclose the other financial terms that are part of the deal.

Among those who have supported and invested in the company are Fountain Healthcare Partners, Delta Partners, Fighting Blindness Ireland, Foundation Fighting Blindness Clinical Research Institute (US) and Enterprise Ireland.

About Author



Related Articles

New Subscriber

Subscribe Here


National Manufacturing Conference & Exhibition 2016

NIBRT Springboard Success Stories

Upcoming Events

  • No upcoming events
AEC v1.0.4